Wenxuan Hong
Wuxi, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
IRF7 links HK1-dependent histone lactylation to fibroblast activation and cardiac fibrosis.
Journal: EMBO molecular medicine
Published: September 24, 2025
The dioxygenase TET2 regulates pathological cardiac hypertrophy.
Journal: Life sciences
Published: May 21, 2025
Histamine N-methyltransferase upregulation, cardiac hypertrophy, and heart failure.
Journal: European heart journal
Published: April 30, 2025
TET3 is a regulator and can be targeted for the intervention of myocardial fibrosis.
Journal: EMBO molecular medicine
Published: February 22, 2025
Suppressor of variegation 3-9 homolog 1 deficiency attenuates cardiac fibrosis and rescues heart failure through TACC2.
Journal: Cardiovascular research
Published: December 18, 2024
The c-Abl-RACK1-FAK signaling axis promotes renal fibrosis in mice through regulating fibroblast-myofibroblast transition.
Journal: Cell communication and signaling : CCS
Published: January 30, 2024
SMARCA4 (BRG1) activates ABCC3 transcription to promote hepatocellular carcinogenesis.
Journal: Life sciences
Published: December 28, 2023
The insulin-like growth factor binding protein-microfibrillar associated protein-sterol regulatory element binding protein axis regulates fibroblast-myofibroblast transition and cardiac fibrosis.
Journal: British journal of pharmacology
Published: April 19, 2023
DNA from macrophages induces fibrosis and vasculopathy through POLR3A/STING/type I interferon axis in systemic sclerosis.
Journal: Rheumatology (Oxford, England)
Published: February 22, 2022
GPR174 knockdown enhances blood flow recovery in hindlimb ischemia mice model by upregulating AREG expression.
Journal: Nature communications
Published: December 24, 2021
HES5-mediated repression of LIGHT transcription may contribute to apoptosis in hepatocytes.
Journal: Cell death discovery
Published: September 07, 2021
Last Updated: 09/26/2026